PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement

2026-03-13 - 00:46

— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI — TOKYO, March 13, 2026 /PRNewswire/ — PRISM BioLab Co., Ltd. (“PRISM”) and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the “Collaboration”) to develop an integrated, AI-navigated, physics-guided platform for